Biogen is the latest big biotech to make a play in protein degradation. The Massachusetts-based company has announced a deal to use Neomorph’s molecular glue degrader discovery platform to go ...

Biogen has ducked out of a four-year-old collaboration ... It inhibits the nuclear export protein exportin-1 (XPO1), the same target as Karyopharm's approved cancer therapy Xpovio (selinexor ...

After getting a green light from the European Commission, Biogen’s Skyclarys is the first ... that lead to low levels of frataxin, a protein necessary for the correct functioning of mitochondria ...

"If we eat a high protein load late in the night, then our stomach produces disproportionately more acid to digest that," Panda said. This combination results in more acid sitting around in the ...

Oct. 26, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq ... reductions in proteinuria levels as assessed by the urinary protein:creatinine ratio (UPCR) and stabilization of kidney function, as ...